Humana Inc. (NYSE:HUM) Shares Acquired by Ontario Teachers Pension Plan Board

Ontario Teachers Pension Plan Board boosted its stake in Humana Inc. (NYSE:HUM) by 6.5% during the third quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 1,173,535 shares of the insurance provider’s stock after buying an additional 71,910 shares during the quarter. Humana makes up about 3.2% of Ontario Teachers Pension Plan Board’s holdings, making the stock its 14th biggest position. Ontario Teachers Pension Plan Board owned about 0.97% of Humana worth $371,705,000 as of its most recent filing with the SEC.

Several other hedge funds also recently bought and sold shares of HUM. Swedbank AB boosted its stake in shares of Humana by 3.0% during the third quarter. Swedbank AB now owns 105,976 shares of the insurance provider’s stock valued at $33,567,000 after acquiring an additional 3,085 shares during the last quarter. Heritage Oak Wealth Advisors LLC purchased a new stake in shares of Humana during the second quarter worth about $3,456,000. Mandatum Life Insurance Co Ltd grew its holdings in shares of Humana by 115.4% during the third quarter. Mandatum Life Insurance Co Ltd now owns 14,000 shares of the insurance provider’s stock worth $4,434,000 after buying an additional 7,500 shares in the last quarter. APG Asset Management US Inc. lifted its stake in shares of Humana by 3.0% during the second quarter. APG Asset Management US Inc. now owns 67,669 shares of the insurance provider’s stock valued at $25,274,000 after buying an additional 1,955 shares during the period. Finally, Cetera Advisors LLC boosted its position in Humana by 472.1% during the first quarter. Cetera Advisors LLC now owns 10,098 shares of the insurance provider’s stock worth $3,501,000 after acquiring an additional 8,333 shares during the last quarter. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Humana Stock Up 2.5 %

HUM stock opened at $278.01 on Wednesday. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.67. The firm has a 50 day simple moving average of $278.54 and a 200-day simple moving average of $331.29. The company has a market capitalization of $33.48 billion, a P/E ratio of 24.62, a PEG ratio of 2.17 and a beta of 0.52. Humana Inc. has a twelve month low of $213.31 and a twelve month high of $527.18.

Humana (NYSE:HUM) last issued its earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.48 by $0.68. The business had revenue of $29.30 billion for the quarter, compared to analyst estimates of $28.66 billion. Humana had a net margin of 1.18% and a return on equity of 13.20%. On average, equities research analysts predict that Humana Inc. will post 15.86 earnings per share for the current fiscal year.

Humana Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st will be given a $0.885 dividend. The ex-dividend date is Tuesday, December 31st. This represents a $3.54 annualized dividend and a dividend yield of 1.27%. Humana’s payout ratio is 31.36%.

Wall Street Analysts Forecast Growth

HUM has been the subject of several analyst reports. Wells Fargo & Company cut their price target on Humana from $387.00 to $290.00 and set an “overweight” rating for the company in a report on Monday, November 4th. JPMorgan Chase & Co. increased their target price on Humana from $332.00 to $396.00 and gave the stock a “neutral” rating in a research report on Wednesday, August 21st. UBS Group decreased their price target on Humana from $380.00 to $250.00 and set a “neutral” rating on the stock in a research note on Friday, October 4th. Royal Bank of Canada dropped their price objective on shares of Humana from $400.00 to $265.00 and set an “outperform” rating for the company in a research note on Tuesday, October 8th. Finally, Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $395.00 target price on shares of Humana in a research report on Tuesday, October 1st. Twenty investment analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $315.86.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.